Dr. Fei Geng, LEL.

Overview

Dr. Geng is currently teaching Molecular Biology, Biochemistry, Immunology and Virology, Genomics and Proteomics at W.Booth School of Engineering Practice and Technology.

From 2012 to 2013, Dr. Geng was part of SGS Life Sciences as a scientist in Biotechnology. He has in-depth knowledge of pharmaceutical industry guidelines such as Good Manufacturing Practice (GMP) and healthcare compliance policies.

Dr. Geng specializes in the research areas of cancer biology, biochemistry and cell biology.

Dr. Geng graduated from Jining Medical College in China in 2001. As he practised clinical medicine as an intern, Dr. Geng realized the lack of effective therapy for diseases such as cancer and thus decided to develop his career into the basic research on cancer therapeutics. In 2004, Dr. Geng received his masters degree in Biochemistry at Fudan University and successfully discovered the prognostic biomarker for lung cancer patients based upon the results from the biochemical studies as well as the statistical analysis of clinical studies.

In 2004, Dr. Geng came to Canada and started his PhD studies on the molecular mechanisms of breast cancer cell death under the supervision of Dr. David Andrews and Dr. Brian Leber in Department of Biochemistry and Biomedical Sciences at McMaster University. During his PhD studies, Dr. Geng discovered a novel cancer cell death signaling pathway, which could be utilized to treat the recurrent breast cancer that is resistant to chemotherapy.

In May 2013, Dr. Geng joined the Bachelor of Technology Program as Assistant Professor.

Did you know?

Dr. Geng conducted the analytical method development and method validation involved in protein drug development.

Fei is the member of American Society of Cell Biology (ASCB) and American Association of Cancer Research (AACR).